P-gp/BCRP-IN-2 (compound 15), an oxadiazole derivative, functions as a dual inhibitor targeting both the ABC transporter P-glycoprotein (IC50: 1.6 nM) and BCRP (IC50: 600 nM). Additionally, it bolsters the anti-proliferative impact of Doxorubicin in the
Molecular Weight:
557.64
Formula:
C32H35N3O6
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
